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Abstract
Background Hypocitraturia is considered a major risk factor
for calcium stone formation. However, there is no widely
accepted reference database of urinary citrate excretion in chil-
dren. The aim of our study was to determine the amount of
citrate eliminated in the urine over a 24-h period in a pediatric
cohort and to determine an optimal unit reflecting excretion.
Methods The study cohort comprised 2,334 healthy boys and
girls aged 2–18 years. The levels of urinary citrate were
assessed by an enzymatic method in 24-hour urine and
expressed in absolute values, as urinary concentration,
citrate/creatinine ratio, per kilogram of body weight, in rela-
tion to 1.73 m2, and as the calcium/citrate index.
Results Similar incremental age-related citraturia rates were
observed in both male and female subjects until puberty
during which time citrate excretion became significantly
higher in girls. Urinary citrate adjusted for creatinine and for
body weight showed a significantly decreasing trend with
increasing age in both sexes. Urinary citrate corrected for
body surface was weakly correlated with age. Thus, the as-
sumption of 180 mg/1.73 m2/24 h for males and 250 mg/
1.73 m2/24 h for females as lower cut-off values appeared to
be reliable from a practical perspective.
Conclusions We found distinct sex-dependent differences in
citraturia at the start of puberty, with significantly higher
values of urinary citrate in girls than in boys. Further prospec-
tive studies are warranted to elucidate whether this difference
represents a differentiated risk of urolithiasis.
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Introduction
Low urinary citrate excretion is recognized as a major risk factor
for calcium stone formation. The inhibitory effects of citrate on
crystal formation in urine are complex. Citrate creates soluble
complexes with calcium, thereby effectively reducing urinary
calcium supersaturation and preventing the nucleation of both
calcium oxalate and calcium phosphate [1, 2]. In addition, citrate
can directly inhibit calcium oxalate crystal growth, aggregation
and attachment to renal epithelial cells by adsorbing to crystal
surfaces [3, 4]. Citrate enhances the inhibitory effect of Tamm–
Horsfall protein on calcium oxalate aggregation and may reduce
the expression of urinary osteopontin, which is a common
component of the urinary stone matrix [5].
Changes in urinary citrate level are predominantly influenced
by the acid–base status. Both systemic and intracellular acidosis
may inhibit renal citrate output if the citrate reabsorption and
metabolism in the proximal tubule becomes upregulated in order
to counteract those disorders. Therefore, higher urine pH tends
to be associated with higher urine citrate [1, 6, 7].
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Hypocitraturia is a frequent co-occurring metabolic abnor-
mality among children and adolescents suffering from renal
stones, with a reported incidence of 10–64 % [8–10]. Such
high discrepancies in the incidence of hypocitraturia are due to
a number of factors, including the different reference values
for urinary citrate adopted by researchers and whether the
examinations are provided on random or on 24-h collection
urine samples. There are also inconsistencies in pediatric
studies regarding the effects of age and gender on the urinary
excretion of citrate. According to some investigators, the
difference between boys and girls begins at puberty [11, 12]
and, consequently, commonly used reference values for uri-
nary citrate in younger children cannot be used after this age.
Whereas some authors have stressed the need to establish
daily total citrate excretion values in children, analogically to
adult reference values, others have emphasized that the actual
urinary citrate concentration might be much more important
than the total 24-h urinary citrate output [13, 14].
We have hypothesized that 24-h urinary citrate excretion
changes with age during the growth period and differs be-
tween the sexes following the onset of puberty. Therefore, in
this study we determined (1) 24-h urinary citrate excretion in
healthy pre-school- and school-children, (2) evaluated wheth-
er citrate output changes with age during growth and whether
this change (if present) is sex-dependent(3) determined which
units expressing urinary citrate were the most appropriate
from a practical perspective.
Methods
Study population This prospective cohort study was carried
out in the Department of Pediatric Nephrology, University
Children’s Hospital in Bialystok during the period 2006–
2012. In total, 2,334 healthy Caucasian children and adoles-
cents aged 2–18 (median 10.38) years were enrolled, with
equal numbers of both sexes. A group of 1,050 subjects had
taken part in our previous investigation [15]. The study pop-
ulation was divided into 16 age groups, consisting of 150
subjects in each 1-year group (75 boys, 75 girls) except for
the youngest group (third year of life) which included 84
children (42 of each sex). The children/adolescents were
mainly volunteers and had been approached while visiting
the academic center for treatment of monosymptomatic pri-
mary nocturnal enuresis or inguinal hernia or were healthy
children of hospital staff families. The exclusion criteria in-
cluded abnormalities in dipstick urinalysis (Bayer Diagnostic,
Bridgend, UK), any infections or medications, diseases
known to affect urinary citrate excretion (i.e., renal tubular
acidosis, chronic diarrhea, inflammatory bowel diseases), and
inadequate 24-h urine collection assessedwith urine creatinine
excretion according to Remer et al. [16]. None of the partic-
ipants reported a history of urolithiasis, and their screening
based on ultrasonography excluded urinary stones and/or
nephrocalcinosis. All subjects were evaluated using the same
protocol, which included anthropometric measurements
[weight, height, body mass index (BMI)], and were requested
to continue their customary diet during the study. Both parents
and children (when the latter were aged >15 years) gave
informed consent for the study. The study was approved by
the ethics committee of the Medical University of Bialystok.
A single 24-hour urine collection was provided at home. After
voiding, urine was stored in a sterile container at 4 °C without
preservatives, and all measurements were conducted in hos-
pital laboratory within 24 h of the end of the collection period.
Urinary measurements Urinary calcium and creatinine were
measured using a Cobas-Integra 800 analyzer and Roche
reagents (Roche, Indianapolis, IN). Urinary pH was deter-
mined using a microcomputer pH-meter (model CP-315 M;
Elmetron, Zabrze, Poland). Urinary citrates were assessed by
an enzymatic method using a commercial set (R-Biopharm
AG, Darmstadt, Germany). Twenty-four-hour citrate excre-
tion was expressed in absolute values, adjusted for urinary
creatinine, per kilogram of body weight, related to the 1.73 m2
of body surface area, and as urinary concentration. The uri-
nary calcium/citrate ratio was also determined as a stone risk
index. Renal ultrasonography was carried out by a certified
radiologist using high-resolution equipment.
Statistical analyses Median values of the above specified
variables for the entire male and female populations and each
1-year subgroupwere analyzed and reported. Additionally, for
further analysis the subjects were divided into three age sub-
groups: 2–6.99, 7–12.99 and 13–17.99 years. Statistical anal-
yses were performed using Statistica®, ver. 10.0 PL (StatSoft
Inc, Tulsa OK). The Mann–Whitney U test was used for
comparisons between two independent parameters, and the
correlations were made with Spearman test. A p value of
<0.05 was considered to be statistically significant.
Results
Comparison of results in boys and girls The comparison of
urinary excretion parameters in male and female study partic-
ipants are given in Table 1. Compared to boys, the girls
presented with significantly higher daily urinary citrate excre-
tion independent of its manner of expression. The median
24-h citrate excretion was 476 and 400 mg/24 h in girls and
boys, respectively. The differences between boys and girls in
urinary citrate were more pronounced when adjusted for cre-
atinine (683 and 509 mg/g creatinine/24 h in girls and boys,
respectively) or per kilogram of body weight (12.84 and
10.45 mg/kg/24 h, respectively) as male subjects had a
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significantly higher weight and creatinine excretion. Calciuria
was equal in both sexes, while median urinary pHwas slightly
but significantly lower in boys (6.29 vs. 6.39). As a conse-
quence, the median urinary calcium/citrate ratio was signifi-
cantly higher in boys (0.18 vs. 0.13 mg/mg).
Age-related changes in urinary citrate excretion in boys and
girls The age-related changes in urinary citrate excretion in
boys and girls are shown in Fig. 1. In girls, the daily excretion
rate of citrate rose from 144mg at age 3 years to 715mg at age
17 years; in boys, it rose from 202 mg at age 3 years to 615mg
at age 17 years. The increase in citrate output was similar in
both sexes up to the age of 12 years at which time it increased
sharply in girls. A similar rise in citrate output was observed in
boys 1 year later, but it decreased again in the following years,
resulting in urinary citrate excretion being significantly higher
values in females (Fig. 1a). The median 24-h urinary citrate
concentrations during all study years were higher in girls than
in boys, except for the youngest children during the third year
of life, when it was slightly higher in boys. The median for
24-h urinary citrate concentration rose with age, and this age-
related increase was significant in girls (R=0.157, p<0.05),
but not significant in boys (R=0.024, p>0.05 (Fig. 1b). Fol-
lowing adjustment for creatinine and for body weight, urinary
citrate excretion showed yearly differences but generally pre-
sented a significant trend toward decreasing values with in-
creasing age in both sexes. The median urinary citrate/
creatinine ratio ranged from 985 mg/g at age 3 years to
275 mg/g at age 16 years in boys and from 997 mg/g at age
4 years to 504 mg/g at age 16 years in girls (Fig. 1c). The
values for urinary citrate excretion expressed per 1.73 m2 of
standard body surface area clearly differed between sexes
beginning from age 14 years and were higher in female. The
relationships with age displayed a weak positive correlation in
girls (R=0.095) and a weak negative correlation in boys
(R=−0.093) (Fig. 1e). The urinary calcium/citrate ratio was
higher in boys than in girls and exhibited trends towards
increasing values with age in both genders (R=0.204 and
R=0.141, respectively). A sharp rise in the ratio beginning
from age 14 was found in boys (Fig. 1f).
Comparison of results in boys and girls according to three age
subgroups: 2–6.99, 7–12.99 and 13–17.99 years In children
aged 2–6.99 years, weight, BMI, urinary pH, creatinine, and
calcium as well as the daily total excretion of citrate, citrate per
kilogram of body weight and per 1.73 m2 did not differ signif-
icantly between sexes (Table 2). Urinary citrate adjusted for
creatinine, citrate concentration and calcium/citrate ratio dif-
fered slightly but significantly between boys and girls. In the
age subgroups 7–12.99 and 13–17.99 years, despite a higher
bodyweight and BMI in boys, the urinary citrate excretion rates
were higher in girls independent of its expression.Median urine
pH values decreased with increasing age and additionally were
lower in male participants. We did not find significant differ-
ences in either urinary pH or citrate excretion betweenmale and
female participants aged 2–6.99 years, whereas in older male
subgroups, the urinary pH and citrate excretion were signifi-
cantly lower than those in girls (Table 2).
Table 3 provides the 5th, 10th, 25th and 50th percentiles for
urinary citrate excretion in children with stratification into three
age subgroups, namely, 2–6.99, 7–12.99 and 13–17.99 years.
Discussion
All children with renal stones and nephrocalcinosis should
undergo a metabolic evaluation to identify the etiology of the
Table 1 Comparison of urinary excretion parameters in male and female study participants
Demographic and urinary excretion parameters Boys (n = 1,167) Girls (n = 1,167) Significance (p)
Age (years) 11.30 (3.43–17.31) 11.49 (3.63–17.71) 0.89
Weight (kg) 43.00 (16.00–77.00) 40.00 (16.00–64.00) <0.001
BMI (kg/m2) 18.47 (14.12–24.45) 18.15 (14.12–23.68) <0.001
Urine pH 6.29 (5.66–7.03) 6.39 (5.69–7.05) <0.001
Calcium (mg/kg/24 h) 1.81 (0.75–3.79) 1.83 (0.73–3.41) 0.66
Creatinine (g/24 h) 0.94 (0.28–1.79) 0.72 (0.24–1.28) <0.001
Citrates (mg/dL) 46.68 (10.87–129.59) 62.17 (18.39–196.45) <0.001
Citrates (mg/24 h) 400.43 (102.23–1,104.19) 476.51 (141.29–1,261.36) <0.001
Citrates (mg/g creat/24 h) 509.35 (118.88–1,341.40) 683.06 (242.22–1,671.05) <0.001
Citrates (mg/kg/24 h) 10.45 (2.53–25.93) 12.84 (4.50–31.46) <0.001
Citrates (mg/1.73 m2/24 h) 560.81 (142.70–1,346.81) 677.76 (241.72–1,590.76) <0.001
Calcium/citrates (mg/mg) 0.18 (0.05–0.68) 0.13 (0.04–0.50) <0.001
Values are presented as the median, with the range (5 %–95 %) given in parenthesis.
BMI Body mass index
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disease. Several recent studies have indicated hypocitraturia as
one of prevalent and most important causative factors of these
conditions [9, 10, 17, 18]. However, normative data on urinary
citrate excretion during development in terms of clinical va-
lidity, the units used and possible changes with age and gender
distinction are not widely acceptable. Hypocitraturia in chil-
dren has been defined as 24-h citrate excretion of <400 mg/g
creatinine [19] or <180 mg/g creatinine regardless of gender
[20]. Other definitions include sex-dependent differences and
consider the lower limits to be a daily urine citrate of 125 mg/g
Fig. 1 Age-dependent changes in urinary citrate excretion in healthy
children and adolescents aged 2–18 years, expressed in absolute values
(a), as urinary concentration (b), adjusted for creatinine (c), per kilogram
of body weight (d), per 1.73 m2 (e) as the calcium/citrate ratio (f) and
linear regression of studied variables vs. age. Linear regression values are
based on trend lines
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creatinine in boys and 300 mg/g creatinine in girls [11] or
1.9 mmol (365 mg)/1.73 m2 in males and 1.6 mmol (310 mg)/
1.73 m2 in females [21].
In our study, we sought to determine the age and sex
dependence of urinary citrate excretion in healthy individuals.
Total citrate voiding rates exhibited a similar yearly
Table 2 Comparison of urinary parameters in male and female study participants stratified into three age groups
Urinary parameters Study participants Significance (p)
Age group: 2–6.99 years
Boys (n = 342) Girls (n = 342)
Age (years) 4.77 (2.47–6.71) 4.78 (2.75–6.66) 0.23
Weight (kg) 18.50 (13.50–28.00) 18.50 (13.55–25.00) 0.25
BMI (kg/m2) 15.61 (13.50–18.89) 15.44 (13.15–18.18) 0.37
Urine pH 6.52 (5.71–7.16) 6.49 (5.69–7.30) 0.73
Calcium (mg/kg/24 h) 1.87 (0.88–3.72) 1.90 (0.76–3.29) 0.71
Creatinine (g/24 h) 0.34 (0.18–0.51) 0.33 (0.22–0.44) 0.51
Citrates (mg/dL) 40.99 (11.21–127.69) 52.09 (15.22–135.34) <0.001
Citrates (mg/24 h) 258.19 (67.14–659.06 278.77 (87.17–734.13 0.14
Citrates (mg/g creat/24 h) 763.45 (242.69–1,778.37) 863.19 (290.36–2,369.60) 0.04
Citrates (mg/kg/24 h) 13.59 (4.21–3.90) 15.06 (5.22–41.40) 0.06
Citrates (mg/1.73 m2/24 h) 591.15 (176.97–1,468.67) 650.56 (218.58–1,726.39) 0.09
Calcium/citrates (mg/mg) 0.15 (0.05–0.48) 0.13 (0.03–0.42) <0.001
Age group: 7–12.99 years
Boys (n = 450) Girls (n = 450)
Age (years) 10.38 (7.21–12.72) 10.31 (7.27–12.75) 0.33
Weight (kg) 36.00 (23.00–57.00) 35.00 (22.40–53.00) 0.02
BMI (kg/m2) 17.72 (14.26–23.51) 17.36 (14.13–22.49) 0.09
Urine pH 6.22 (5.69–7.01) 6.40 (5.71–7.00) <0.001
Calcium (mg/kg/24 h) 1.91 (0.79–3.75) 1.56 (0.55–3.36) <0.001
Creatinine (g/24 h) 0.80 (0.50–1.12) 0.66 (0.44–0.99) <0.001
Citrates (mg/dL) 50.06 (11.28–127.41) 64.19 (18.81–210.35) <0.001
Citrates (mg/24 h) 425.14 (102.26–989.02 446.11 (161.63–1,067.23 0.003
Citrates (mg/g creat/24 h) 550.38 (139.03–1,212.10) 687.29 (261.44–1,462.17) <0.001
Citrates (mg/kg/24 h) 11.35 (3.13–24.81) 12.76 (4.98–29.92) <0.001
Citrates (mg/1.73 m2/24 h) 599.90 (162.50–1,272.99) 656.66 (253.03–1,498.15) <0.001
Calcium/citrates (mg/mg) 0.17 (0.05–0.60) 0.12 (0.04–0.47) <0.001
Age group:13.00–17.99 years
Boys (n = 375) Girls (n = 375)
Age (years) 15.44 (13.26–17.82) 15.34 (13.31–17.88) 0.64
Weight (kg) 65.20 (42.00–81.90) 55.00 (40.00–69.00) <0.001
BMI (kg/m2) 21.13 (16.44–25.25) 20.45 (17.22–24.24) <0.001
Urine pH 6.22 (5.63–6.90) 6.35 (5.66–6.96) <0.001
Calcium (mg/kg/24 h) 1.71 (0.71–3.79) 1.93 (0.92–3.50) <0.001
Creatinine (g/24 h) 1.40 (0.97–1.94) 1.08 (0.80–1.36) <0.001
Citrates (mg/dL) 43.96 (10.11–142.79) 70.77 (21.30–211.46) <0.001
Citrates (mg/24 h) 490.12 (130.05–1,327.90) 659.58 (230.55–1,589.42) <0.001
Citrates (mg/g creat/24 h) 339.65 (89.68–976.42) 610.83 (216.30–1,403.67) <0.001
Citrates (mg/kg/24 h) 7.69 (2.17–21.98) 12.28 (4.16–28.38) <0.001
Citrates (mg/1.73 m2/24 h) 475.97 (130.82–1,329.07) 729.45 (248.75–1,696.49) <0.001
Calcium/citrates (mg/mg) 0.22 (0.06–0.80) 0.16 (0.05–0.60) <0.001
Values are presented as the median, with the range (5–95 %) given in parenthesis.
BMI, Body mass index
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increments in boys and girls up to the age of 11 years,
reflecting increased food consumption, muscle mass and body
size as children become older. Girls at age 12 years and boys at
approximately age 13 years, ages that correspond to the onset
of puberty in girls and boys, respectively, showed sharp in-
creases in citrate output. Afterwards, between ages 14 and
18 years the daily total citrate excretion was already signifi-
cantly higher in girls. Our results suggest that female sex
hormones may play an important role in determining the
urinary citrate level. Other studies conducted on premeno-
pausal and menopausal women to assess the influence of
estrogen on urinary chemical parameters showed that citrate
excretion varied during the menstrual cycle and was higher
during the high compared to the low basal body temperature
phases, gradually falling in menopausal women [22, 23]. The
distinction in urinary citrate excretion between the sexes can
also be partially explained by ascertained differences in uri-
nary pH. In our study, median urinary pH values decreased
with increasing age and additionally were lower in male than
in female participants—these changes were in similar direc-
tions to those observed for citrate when calculated in relation
to weight or creatinine excretion.We can speculate that the fall
in urinary pH with age is due to changes in dietary habits and
exertion.
The reference values for urinary citrate which have hitherto
been used in children are associated with urinary creatinine
[11, 19, 20] or to the 1.73 m2 of standard body surface area
[21]. In our study, the median of urinary citrate/creatinine ratio
was higher in girls than in boys (683 vs. 509 mg/g) and
showed a significant trend to decrease with increasing age in
both sexes (R=−0.208 and R=−0.421), respectively. The 5th
percentile of the ratio was 170 mg/g for the entire study
population and was similar to that found by Srivastava et al.
[20], whereas it amounted to 118 and 242 mg/g in boys and
girls, respectively. Thus, adoption of a single definition of
hypocitraturia (i.e., <180 mg/g creatinine or <400 mg/g cre-
atinine) for both sexes and among different age groups within
the pediatric population appears to be problematic. Because of
the relevant age and sex dependence of citraturia observed in
our study, the definition of hypocitraturia when corrected for
creatinine should be established based on normative data for
both sexes and for separate age periods up until adulthood.
Similar observations with regard to the urinary citrate/
creatinine ratio in children were reported by Borawski et al.
who proposed stratification of urinary reference values for
citraturia according to quintiles of age [24].
We found that the threshold of lower normal limits (5th
percentile) for the citrate/creatinine ratio were distinctly differ-
ent for boys and girls and also age dependent, being 242 and
290 mg/g, respectively, in the subgroup aged 2–6.99 years, 139
and 261mg/g, respectively, in the subgroup aged 7–12.99 years,
and 89 and 216 mg/g, respectively, in the subgroup aged 13–
17.99 years. The lower citrate level and especially the higher
creatinine excretion in adolescent males compared to girls
seems to be the explanation for an increasing sex-related diver-
gence in the citrate/creatinine ratio within these age ranges.
In our study, urinary citrate related to 1.73 m2 of standard
body surface area presented as approximate median
Table 3 Values of 5th, 10th, 25th
and 50th percentiles for 24-h uri-
nary citrate excretion for boys and
girls with stratification into three
age subgroups
Urinary citrate excretion parameters Boys Girls
5 % 10 % 25 % 50 % 5 % 10 % 25 % 50 %
Age group: 2–6.99 years
Citrates (mg/dL) 11.2 14 26 41 15.2 20 30 52
Citrates (mg/24 h) 67.1 108 168 259 87.2 115 169 279
Citrates (mg/g creatinine/24 h) 242 329 516 763 290 365 558 863
Citrates (mg/kg/24 h) 4.2 6.1 9.3 13.5 5.2 6.8 9.6 15,1
Citrates (mg/1.73 m2/24 h) 177 264 401 591 218 284 408 651
Age group: 7–12.99 years
Citrates (mg/dL) 11.3 16 29 50 18.8 25 38 64
Citrates (mg/24 h) 102 161 280 425 161 213 308 446
Citrates (mg/g creatinine/24 h) 139 220 360 550 261 341 490 687
Citrates (mg/kg/24 h) 3.1 4.5 7.4 11.3 5.0 6.4 9.2 12.8
Citrates (mg/1.73 m2/24 h) 162 240 400 600 253 331 481 657
Age group: 13–17.99 years
Citrates (mg/dL) 10.1 15 27 44 21.3 28 44 70
Citrates (mg/24 h) 130 206 323 490 230 313 444 660
Citrates (mg/g creatinine/24 h) 89 144 231 340 216 275 430 611
Citrates (mg/kg/24 h) 2.2 3.2 5.2 7.7 4.2 5.3 8.3 12.3
Citrates (mg/1.73 m2/24 h) 130 200 327 476 248 328 486 729
1580 Pediatr Nephrol (2014) 29:1575–1582
values in boys and girls for subgroups aged 2–6.99 and 7–
12.99 years (591 vs. 650 and 599 vs. 656 mg/1.73 m2, respec-
tively). The median value in boys was significantly lower than
that in girls in the subgroup aged 13–17.99 years (475 vs.
729 mg/1.73 m2, respectively). This result is important because
this manner of expression exhibited much less variability than
the other ‘units’ within the groups of boys and girls, respec-
tively, and there was only a weak positive correlation with age
in girls (r=0.095) and a weak inverse trend with age in boys
(r=−0.093). The 5th percentiles established for the three age
subgroups were at 177, 162 and 130 mg/1.73 m2 (in increasing
age subgroups) for boys and 218, 253 and 248 mg/1.73 m2 (in
increasing age subgroups) for girls. Therefore, from a practical
perspective, we recommend simplifying the reference values
for urinary citrate expression in children of all ages and to use
180 mg/1.73 m2/24 h in males and 250 mg/1.73 m2/24 h in
females for hypocitraturia screening.
However, we should be aware that urinary citrate levels
that fall below the 5 % of reference range suggest a need for
investigation in terms of possible metabolic acidosis (e.g.,
renal tubular acidosis) [11, 13]. Additionally, the optimal
urinary citrate excretion for calcium stone formers should be
closer to the statistical average than to the lower limits of the
healthy reference group, and any value lower than the
mean/median for 24 h may still represent a potential risk for
kidney stone formation or recurrence, particularly in patients
with coincident hypercalciuria [14, 20]. Therefore, we show
here the 5th, 10th, 25th, and 50th percentiles for urinary citrate
expressed using different units for three age periods, as these
may also be applicable in clinical practice, such as for pediat-
ric stone formers treated with citrate supplements (Table 3).
Many authors have postulated that not only the absolute
urinary calcium or citrate concentrations, but alternatively the
relative proportion of the two, determine the risk of stone forma-
tion [20, 25, 26]. It has been shown that a urinary calcium/citrate
index of 0.326 mg/mg can discriminate well between pediatric
stone formers and healthy controls [20]. In this study, the me-
dians of the above quotient were below that value in the all-age
group. Nevertheless, the age-related continuous increase in the
urinary calcium/citrate ratio, particularly in boys aged >14 years,
was detected in our study. This may partly imply a higher
prevalence of urolithiasis in older individuals and also a higher
susceptibility to kidney stone disease among males.
There are a few limitations to our study. The most impor-
tant weakness is perhaps that we have not extended our
investigation to include infants and children aged ≤2 years
who were not toilet-trained. Furthermore, the subgroup of
children in their third year of life was quite small compared
to the other age groups, and the results in this group did not
match general trends of our findings. Finally, our study cohort
is homogeneous, and other populations with more varied
racial and ethnic groups may be needed for validation of our
results over time.
Our results, based on a large representative population of
healthy children and adolescents, may provide useful norma-
tive data to screen for urinary citrate, particularly in individ-
uals at risk of urolithiasis and/or nephrocalcinosis. In contrast
to other available reference values in children, this report
shows specific and more precise cut-off points in citrate
excretion by indicating differences between boys and girls in
critical stages of growth. The determination of a distinct
urinary citrate reference may be of value in monitoring man-
agement with citrate supplements in pediatric stone disease.
Acknowledgments This study was supported by a research grant from
the Medical University of Bialystok (No 123-41763L).
Open Access This article is distributed under the terms of the Creative
Commons Attribution License which permits any use, distribution, and
reproduction in any medium, provided the original author(s) and the
source are credited.
References
1. Pak CY (1994) Citrate and renal calculi: an update. Miner Electrolyte
Metab 20:371–377
2. Nicar MJ, Hill K, Pak CYC (1987) Inhibition by citrate of spontaneous
precipitation of calcium oxalate in vitro. J Bone Miner Res 2:215–220
3. Sheng X, Jung T, Wesson JA, Ward MD (2005) Adhesion at calcium
oxalate crystal surfaces and the effect of urinary constituents. Proc
Natl Acad Sci USA 102:267–272
4. Grohe B, O’Young J, Langdon A, Karttunen M, Goldberg HA,
Hunter GK (2011) Citrate modulates calcium oxalate growth by
face-specific interactions. Cells Tissues Organs 194:176–181
5. Hess B, Zipperle L, Jaeger P (1993) Citrate and calcium effects on
Tamm-Horsfall glycoprotein as a modifier of calcium oxalate crystal
aggregation. Am J Physiol 265:F784–F791
6. Hamm LL (1990) Renal handling of citrate. Kidney Int 38:728–735
7. Simpson DP (1983) Citrate excretion: a window on renal metabo-
lism. Am J Physiol 244:F223–F234
8. Milliner DS, Murphy ME (1993) Urolithiasis in pediatric patients.
Mayo Clin Proc 68:241–248
9. Tefekli A, Esen T, Ziylan O, Erol B, Armagan A, Ander H, Akinci M
(2003) Metabolic risk factors in pediatric and adult calcium oxalate
stone formers: is there any differences? Urol Int 70:273–277
10. VanDervoort K, Wiesen J, Frank R, Vento S, Crosby V, Chandra M,
Trachtman H (2007) Urolithiasis in pediatric patients: a single center
study of incidence, clinical presentation and outcome. J Urol 177:
2300–2305
11. NormanME, Feldman NI, Cohn RM, Roth KS,McCurdyDK (1978)
Urinary citrate excretion in the diagnosis of distal renal tubular
acidosis. J Pediatr 92:394–400
12. Hoppe B, Langman CB (1997) Hypocitraturia in patients with uro-
lithiasis. Arch Dis Child 76:174–175
13. Milliner DS (2009) In: Avner ED, Harmon WE, Niaudet P,
Yoshikava N (eds) Urolithiasis, in Pediatric Nephrology. Springer,
Berlin, pp 1408–1430
14. Lerma EV (2013) Hypocitraturia. Available at: Emedicine.medscape.
com/article/444968-overview
15. Porowski T, Zoch-ZwierzW,WasilewskaA, SpotykA,Konstantynowicz
J (2007) Normative data on the Bonn Risk Index for calcium oxalate
crystallization in healthy children. Pediatr Nephrol 22:514–520
Pediatr Nephrol (2014) 29:1575–1582 1581
16. Remer T, Neubert A, Maser-Gluth C (2002) Anthropometry-based
reference values for 24-h urinary creatinine excretion during growth
and their use in endocrine and nutritional research. Am J Clin Nutr
75:561–569
17. Sikora P, Roth B, Kribs A, Michalk DV, Hesse A, Hoppe B (2003)
Hypocitraturia is one of the major risk factors for nephrocalcinosis in
very low birth weight (VLBW) infants. Kidney Int 63:2194–2199
18. Kovacevic L, Wolfe-Christensen C, Edwards L, Sadaps M,
Lakshmanan Y (2012) From hypercalciuria to hypocitraturia—a
shifting trend in pediatric urolithiasis. J Urol 188(Suppl 4):1623–
1627
19. Stapleton FB, Kroovand RL (1996) Stones in childhood. In: Coe FL,
Favus MJ, Pak CYC, Parks JH, Preminger GM (eds) Kidney stones:
medical and surgical management. Lippincott-Raven, Philadelphia,
pp 1065–1080
20. Srivastava T, Winston MJ, Auron A, Alon US (2009) Urine calcium/
citrate ratio in children with hypercalciuric stones. Pediatr Res 66:85–90
21. Hoppe B, Kemper MJ (2010) Diagnostic examination of the child
with urolithiasis or nephrocalcinosis. Pediatr Nephrol 25:403–413
22. Kato Y, Yamaguchi S, Kakizaki H, Yachiku S (2005) Influence of
estrus status on urinary chemical parameters related to urolithiasis.
Urol Res 33:476–480
23. Heller HJ, Sakhaee K, Moe OW, Pak CY (2002) Etiological role of
estrogen status in renal stone formation. J Urol 168:1923–1927
24. Borawski KM, Sur RL, Miller OF, Pak CY, Preminger GM, Kolon
TF (2008) Urinary reference values for stone risk factors in children. J
Urol 179:290–294
25. De Foor W, Minevich E, Jackson E, Reddy P, Clark C, Sheldon C,
Asplin J (2008) Urinary metabolic evaluations in solitary and recur-
rent stone forming children. J Urol 179:2369–2372
26. Porowski T, Kirejczyk JK, Konstantynowicz J, Kazberuk A, Plonski
G, Wasilewska A, Laube N (2013) Correspondence betweeen Ca2+
and calciuria, citrate level and pH of urine in pediatric urolithiasis.
Pediatr Nephrol 28:1079–1084
1582 Pediatr Nephrol (2014) 29:1575–1582
